Superior antileukemia effects of targeted knockdown of histone deacetylase 6 and heat shock protein 90 inhibitor and/or bortezomib.

被引:0
|
作者
Bali, P
Balasis, M
Fiskus, W
Pranpat, M
Rocha, K
Kumaraswamy, S
Boyapalle, S
Atadja, P
Bhalla, K
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Novartis Pharmaceut Inc, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:9140S / 9140S
页数:1
相关论文
共 50 条
  • [1] Inhibition of histone deacetylase 6 sensitizes human leukemia and breast cancer cells to inhibitor of heat shock protein 90 and/or bortezomib
    Bali, Purva
    Balasis, Maria
    Fiskus, Warren
    Pranpat, Michael
    Rocha, Kathy
    Kumaraswamy, Sandhya
    Boyapalle, Sandhya
    Atadja, Peter
    Bhalla, Kapil
    CANCER RESEARCH, 2006, 66 (08)
  • [2] Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors
    Bali, P
    Pranpat, M
    Bradner, J
    Balasis, M
    Fiskus, W
    Guo, F
    Rocha, K
    Kumaraswamy, S
    Boyapalle, S
    Atadja, P
    Seto, E
    Bhalla, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) : 26729 - 26734
  • [3] Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90
    Pinzi, Luca
    Benedetti, Rosaria
    Altucci, Lucia
    Rastelli, Giulio
    ACS OMEGA, 2020, 5 (20): : 11473 - 11480
  • [4] Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90)
    Bonanni, Davide
    Citarella, Andrea
    Moi, Davide
    Pinzi, Luca
    Bergamini, Elisa
    Rastelli, Giulio
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (09) : 1474 - 1502
  • [5] Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90
    Ping Liu
    Ji Xiao
    Yiliang Wang
    Xiaowei Song
    Lianzhou Huang
    Zhe Ren
    Kaio Kitazato
    Yifei Wang
    Molecular Medicine, 2021, 27
  • [6] Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90
    Liu, Ping
    Xiao, Ji
    Wang, Yiliang
    Song, Xiaowei
    Huang, Lianzhou
    Ren, Zhe
    Kitazato, Kaio
    Wang, Yifei
    MOLECULAR MEDICINE, 2021, 27 (01)
  • [7] Multiple-target drugs: Inhibitors of heat shock protein 90 and of histone deacetylase
    Budillon, A
    Bruzzese, F
    Di Gennaro, E
    Caraglia, M
    CURRENT DRUG TARGETS, 2005, 6 (03) : 337 - 351
  • [8] Synergistic Action of Heat-Shock Protein-90 Inhibitor NVP-AUY922 with Histone Deacetylase Inhibition
    Kaiser, M.
    Lamottke, B.
    Jensen, M. R.
    Quadt, C.
    Garcia-Echeverria, C.
    Mieth, M.
    Heider, U.
    Sezer, O.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S129 - S129
  • [9] Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3+ T-Regulatory Cells
    de Zoeten, Edwin F.
    Wang, Liqing
    Butler, Kyle
    Beier, Ulf H.
    Akimova, Tatiana
    Sai, Hong
    Bradner, James E.
    Mazitschek, Ralph
    Kozikowski, Alan P.
    Matthias, Patrick
    Hancock, Wayne W.
    MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (10) : 2066 - 2078
  • [10] Increasing radioiodide accumulation in thyroid cancer cells by inhibition of histone deacetylase and heat shock protein 90
    Yu, Kyoung Hyun
    Youn, Hye Won
    So, Min Kyoung
    Kang, Keon Wook
    Jeong, Jae Min
    Lee, Doug Soo
    Chung, J. K.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50